Transit Scientific announces the successful clinical deployment of XO Cath, an embolic delivery microcatheter intended for interventional procedures.
Richard Saxon (North County Radiology Associates, San Diego, USA), performed the inaugural procedure utilising the XO Cath 2.0Fr 130cm microcatheter with a Bern-shaped tip. The prostatic artery embolization (PAE) case involving significant vessel tortuosity demonstrated the microcatheter’s capabilities, a recent press release states, specifically its manoeuvrability while navigating tortuous anatomy.
Saxon accessed the treatment site from the right femoral artery, beginning in the left prostatic artery where he deployed 100 to 300, and 300 to 500um microspheres and then tracked XO Cath to a wedged position. After treating the left prostatic artery, he navigated to the right side through a 5Fr support catheter and finished treatment on the second side.
Saxon commented on the procedure: “The pushability, visibility, and trackability of the XO Cath were notable, enabling precise manoeuvrability even in challenging anatomical conditions. It tracked incredibly well around tight turns and bends, allowing for distal and precise embolic delivery. In addition, the microcatheter’s luminal size allows for strong injection rates and high-quality imaging.”
Jennifer Arnold, president and CEO of Transit Scientific commented: “The successful debut of XO Cath in its inaugural procedure underscores its potential to redefine the standards of care in interventional radiology and interventional oncology. Transit Scientific remains committed to advancing medical innovation and aims to empower clinicians worldwide with transformative technologies like XO Cath.”
